News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
132,897 Results
Type
Article (6800)
Company Profile (83)
Press Release (126014)
Section
Business (43800)
Career Advice (153)
Deals (6087)
Drug Delivery (9)
Drug Development (19399)
Employer Resources (15)
FDA (1926)
Job Trends (3056)
News (69801)
Policy (3742)
Tag
Academia (713)
Alliances (14977)
Alzheimer's disease (375)
Approvals (1946)
Artificial intelligence (90)
Bankruptcy (36)
Best Places to Work (2739)
Biotechnology (65)
Breast cancer (81)
Cancer (522)
Cardiovascular disease (30)
Career advice (141)
Cell therapy (64)
Clinical research (15395)
Collaboration (281)
Compensation (124)
COVID-19 (298)
C-suite (49)
Cystic fibrosis (27)
Data (526)
Diabetes (51)
Diagnostics (851)
Drug discovery (57)
Earnings (13935)
Events (21290)
Executive appointments (148)
FDA (2110)
Funding (172)
Gene therapy (44)
GLP-1 (155)
Government (374)
Healthcare (3123)
Infectious disease (313)
Inflammatory bowel disease (41)
IPO (3059)
Job creations (543)
Job search strategy (129)
Layoffs (59)
Legal (594)
Lung cancer (81)
Lymphoma (32)
Manufacturing (46)
Medical device (891)
Medtech (892)
Mergers & acquisitions (3128)
Metabolic disorders (106)
Neuroscience (477)
NextGen: Class of 2025 (982)
Non-profit (913)
Northern California (668)
Obesity (53)
Opinion (41)
Parkinson's disease (33)
People (12795)
Phase I (5612)
Phase II (6557)
Phase III (4622)
Pipeline (216)
Postmarket research (373)
Preclinical (2766)
Press Release (38)
Radiopharmaceuticals (68)
Rare diseases (61)
Real estate (1068)
Regulatory (3054)
Research institute (890)
Series A (32)
Southern California (493)
Startups (1069)
United States (4574)
Vaccines (60)
Date
Last 7 days (166)
Last 30 days (714)
Last 365 days (9412)
2025 (734)
2024 (9503)
2023 (10072)
2022 (12201)
2021 (12588)
2020 (10620)
2019 (8404)
2018 (6317)
2017 (6887)
2016 (6183)
2015 (6895)
2014 (5002)
2013 (4040)
2012 (4450)
2011 (4798)
2010 (4504)
Location
Africa (113)
Asia (8919)
Australia (1381)
California (1340)
Canada (359)
China (140)
Colorado (51)
Connecticut (88)
Delaware (69)
Europe (20587)
Florida (109)
Illinois (84)
Indiana (122)
Japan (55)
Maryland (191)
Massachusetts (1115)
Minnesota (46)
New Jersey (338)
New York (299)
North Carolina (148)
Northern California (668)
Ohio (36)
Pennsylvania (187)
South America (145)
Southern California (493)
Texas (157)
Utah (34)
Virginia (25)
Washington State (106)
132,897 Results for "c4x discovery".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 3, 2024
December 4, 2024
·
1 min read
Genetown
X4 Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
X4 Pharmaceuticals today announced that management will be participating in the upcoming H.C. Wainwright 2nd Annual BioConnect Investor Conference, taking place on May 20th, 2024, at the Nasdaq Stock Exchange in New York City.
May 13, 2024
·
1 min read
Press Releases
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 1, 2024
November 4, 2024
·
1 min read
C4X Discovery Holdings PLC Announces Divestment of Orexin-1 to Indivior for £15.95m
C4X Discovery Holdings plc, a pioneering Drug Discovery company, announces the execution of an asset purchase agreement for Indivior PLC to acquire the proprietary rights to C4XD’s oral Orexin-1 receptor antagonist, C4X_3256 for substance use disorder, for £15.95 million.
August 1, 2023
·
4 min read
Press Releases
C4X Discovery Holdings Limited announces progress on immuno-inflammation programmes and appointment of new Board members
July 22, 2024
·
6 min read
Press Releases
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 1, 2024
·
1 min read
Press Releases
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 3, 2024
September 4, 2024
·
1 min read
Press Releases
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 1, 2024
August 2, 2024
·
1 min read
Deals
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 3, 2024
X4 Pharmaceuticals today announced that, effective on May 31, 2024, the company issued inducement awards to new employees under the X4 Pharmaceuticals, Inc.
June 3, 2024
·
1 min read
Business
AstraZeneca and C4X Discovery Ink $402M COPD Collaboration
C4X entered into a licensing deal with AstraZeneca to develop an oral treatment for COPD and other inflammatory and respiratory illnesses that could reach $402 million.
November 28, 2022
·
2 min read
·
Mark Terry
1 of 13,290
Next
